Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Usefulness of Bright Light Therapy in the Prevention of Delirium in Patients Undergoing Hematopoietic Stem Cell Transplant (HSCT)

NCT01700816 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01700816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01700816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Usefulness of Bright Light Therapy in the Prevention of Delirium in Patients Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 2012
Completion date
October 31, 2013
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delirium